Servier is a research-based group dedicated to health care.
As the top-ranked French independent pharmaceutical laboratory, Servier reinvests more than 25% of its turnover in Research and Development.
As a result, there are currently 29 new drug candidates under development in the following therapeutic areas: cardiology, oncology, metabolism, neuropsychiatry and rheumatology.
With a presence on 5 continents and in 146 countries, Servier has put a total of 867 million drug treatments in the hands of patients in 2014. 92% of Servier's medicines are prescribed internationally.